Flag Ship Acquisition (ETHZ) Stock Price, News & Analysis

Company Overview

1180 Life Sciences Corp., a clinical-stage biotechnology company, develops therapeutics for unmet medical needs in chronic pain, inflammation, fibrosis, and other inflammatory diseases. Its product development platforms include fibrosis and anti-tumor necrosis factor (anti-TNF) platform, which is under Phase IIb clinical trials that focuses on fibrosis and Anti-TNF; Synthetic Cannabidiol (CBD) Analogs platform, which is under preclinical trials that are man-made derivatives of CBD; and a7nAChR platform, an immune suppressive, which is under preclinical trails that focuses on alpha 7 nicotinic acetylcholine receptor. The company was incorporated in 2016 and is headquartered in Palo Alto, California.

Key Stats

• Today's Range: $5.33 to $6.03
• 50-Day Range: $5.03 to $6.81
• 52-Week Range: $0.70 to $17.46
• Volume: 78,169 shs
• Average Volume: 6.44 million shs
• Market Capitalization: $103.81 million
• P/E Ratio: N/A
• Dividend Yield: N/A
• Price Target: N/A
• Consensus Rating: Sell

Flag Ship Acquisition Stock Analysis - MarketRank™

Flag Ship Acquisition scored higher than 2% of companies evaluated by MarketBeat. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation.

Analyst's Opinion

• Score: 0.5 / 5
• Analyst Rating: Sell

Consensus Rating

Flag Ship Acquisition has received a consensus rating of Sell. The company's average rating score is 1.00, and is based on no strong buy ratings, no buy ratings, no hold ratings, and 1 sell rating.

Amount of Analyst Coverage

Flag Ship Acquisition has received no research coverage in the past 90 days.

Earnings and Valuation

• Score: 0.7 / 5
• Proj. Earnings Growth: N/A

Price to Earnings Ratio vs. the Market

The P/E ratio of Flag Ship Acquisition is -0.03, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.

Price to Book Value per Share Ratio

Flag Ship Acquisition has a P/B Ratio of 0.19. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.

Short Interest

• Score: N/A
• Short Interest Level: N/A

Short Interest

There is no current short interest data available for ETHZ.

Dividend

• Score: 0.0 / 5
• Dividend Strength: N/A

Dividend Yield

Flag Ship Acquisition does not currently pay a dividend.

Dividend Growth

Flag Ship Acquisition does not have a long track record of dividend growth.

News and Social Media

• Score: 1.5 / 5
• News Sentiment: N/A

News Sentiment

Flag Ship Acquisition has a news sentiment score of 0.36. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a lower news sentiment than the 0.71 average news sentiment score of companies.

News Coverage This Week

MarketBeat has tracked 1 news article for Flag Ship Acquisition this week, compared to 1 article on an average week.

Company Ownership

• Score: 0.6 / 5
• Insider Trading: N/A

Insider Buying vs. Insider Selling

In the past three months, Flag Ship Acquisition insiders have not sold or bought any company stock.

Percentage Held by Insiders

15.10% of the stock of Flag Ship Acquisition is held by insiders. A high percentage of insider ownership can be a sign of company health.

Percentage Held by Institutions

4.07% of the stock of Flag Ship Acquisition is held by institutions.

Company Calendar

• Last Earnings: 11/14/2025
• Today: 8/19/2026
• AGM 2026: 8/19/2026
• Micro-Cap Virtual Conference: 8/20/2026
• Fiscal Year End: 12/31/2026

Industry, Sector and Symbol

• Stock Exchange: NASDAQ
• Sector: N/A
• Industry: N/A
• Sub-Industry: N/A
• Current Symbol: NASDAQ:ETHZ
• Previous Symbol: NASDAQ:ATNF
• CIK: 1690080
• Web: 180lifesciences.com
• Phone: (650) 507-0669
• Fax: N/A
• Employees: 7
• Year Founded: N/A

Profitability

• EPS (Trailing Twelve Months): ($159.65)
• Trailing P/E Ratio: N/A
• Forward P/E Ratio: N/A
• P/E Growth: N/A
• Net Income: -$6.17 million
• Net Margins: N/A
• Pretax Margin: -5,295.40%
• Return on Equity: -185.71%
• Return on Assets: -83.12%

Debt

• Debt-to-Equity Ratio: 1.11
• Current Ratio: 10.07
• Quick Ratio: 10.07

Sales & Book Value

• Annual Sales: $4.11 million
• Price / Sales: 25.26
• Cash Flow: N/A
• Price / Cash Flow: N/A
• Book Value: $29.12 per share
• Price / Book: 0.19

Miscellaneous

• Outstanding Shares: 19,012,000
• Free Float: 16,141,000
• Market Cap: $103.81 million
• Optionable: N/A
• Beta: 1.17